A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT05126719 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05126719
- Sponsor
- Shanghai Miracogen Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2024-12-30
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.